Vertex Pharmaceuticals
VRTX
VRTX
1,103 hedge funds and large institutions have $65.6B invested in Vertex Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 132 funds opening new positions, 359 increasing their positions, 438 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.44% less ownership
Funds ownership: 92.37% → 91.94% (-0.44%)
3% less call options, than puts
Call options by funds: $468M | Put options by funds: $480M
18% less repeat investments, than reductions
Existing positions increased: 359 | Existing positions reduced: 438
Holders
1,103
Holding in Top 10
32
Calls
$468M
Puts
$480M
Top Buyers
| 1 | +$956M | |
| 2 | +$381M | |
| 3 | +$327M | |
| 4 |
Morgan Stanley
New York
|
+$268M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$221M |
Top Sellers
| 1 | -$517M | |
| 2 | -$336M | |
| 3 | -$243M | |
| 4 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
-$158M |
| 5 |
D.E. Shaw & Co
New York
|
-$125M |